Methotrexate was first approved to treat rheumatic illnesses in 1959, years before Roe vs. Wade.

Since its reversal, many patients have been delayed or denied this “gold-standard” treatment for conditions that have nothing to do with pregnancy.https://t.co/MAw9YKsR8x

— Los Angeles Times (@latimes) July 13, 2022